155 related articles for article (PubMed ID: 27076625)
1. Epithelial-Mesenchymal Transition and Immune Evasion during Lung Cancer Progression: The Chicken or the Egg?
Datar I; Schalper KA
Clin Cancer Res; 2016 Jul; 22(14):3422-4. PubMed ID: 27076625
[TBL] [Abstract][Full Text] [Related]
2. Regulation of complement-dependent cytotoxicity by TGF-β-induced epithelial-mesenchymal transition.
Goswami MT; Reka AK; Kurapati H; Kaza V; Chen J; Standiford TJ; Keshamouni VG
Oncogene; 2016 Apr; 35(15):1888-98. PubMed ID: 26148233
[TBL] [Abstract][Full Text] [Related]
3. TGFβ1-induced down-regulation of microRNA-138 contributes to epithelial-mesenchymal transition in primary lung cancer cells.
Zhang F; Li T; Han L; Qin P; Wu Z; Xu B; Gao Q; Song Y
Biochem Biophys Res Commun; 2018 Feb; 496(4):1169-1175. PubMed ID: 29407170
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-mesenchymal transition (EMT) signature is inversely associated with T-cell infiltration in non-small cell lung cancer (NSCLC).
Chae YK; Chang S; Ko T; Anker J; Agte S; Iams W; Choi WM; Lee K; Cruz M
Sci Rep; 2018 Feb; 8(1):2918. PubMed ID: 29440769
[TBL] [Abstract][Full Text] [Related]
5. The crosstalk between p38 and Akt signaling pathways orchestrates EMT by regulating SATB2 expression in NSCLC cells.
Kucuksayan H; Akca H
Tumour Biol; 2017 Sep; 39(9):1010428317706212. PubMed ID: 28937318
[TBL] [Abstract][Full Text] [Related]
6. EMT-induced immune evasion: connecting the dots from mechanisms to therapy.
Imodoye SO; Adedokun KA
Clin Exp Med; 2023 Dec; 23(8):4265-4287. PubMed ID: 37966552
[TBL] [Abstract][Full Text] [Related]
7. SPOCK1 is a novel transforming growth factor-β target gene that regulates lung cancer cell epithelial-mesenchymal transition.
Miao L; Wang Y; Xia H; Yao C; Cai H; Song Y
Biochem Biophys Res Commun; 2013 Nov; 440(4):792-7. PubMed ID: 24134845
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal-Epithelial Transition and Circulating Tumor Cells in Small Cell Lung Cancer.
Hamilton G; Rath B
Adv Exp Med Biol; 2017; 994():229-245. PubMed ID: 28560677
[TBL] [Abstract][Full Text] [Related]
9. Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.
Liao TT; Yang MH
Mol Oncol; 2017 Jul; 11(7):792-804. PubMed ID: 28649800
[TBL] [Abstract][Full Text] [Related]
10. Epithelial Mesenchymal Transition in Aggressive Lung Cancers.
Mittal V
Adv Exp Med Biol; 2016; 890():37-56. PubMed ID: 26703798
[TBL] [Abstract][Full Text] [Related]
11. Comparative gene co-expression network analysis of epithelial to mesenchymal transition reveals lung cancer progression stages.
Wang D; Haley JD; Thompson P
BMC Cancer; 2017 Dec; 17(1):830. PubMed ID: 29212455
[TBL] [Abstract][Full Text] [Related]
12. Immunological Consequences of Epithelial-Mesenchymal Transition in Tumor Progression.
Chockley PJ; Keshamouni VG
J Immunol; 2016 Aug; 197(3):691-8. PubMed ID: 27431984
[TBL] [Abstract][Full Text] [Related]
13. Microenvironmental Cues Determine Tumor Cell Susceptibility to Neutrophil Cytotoxicity.
Gershkovitz M; Fainsod-Levi T; Khawaled S; Shaul ME; Sionov RV; Cohen-Daniel L; Aqeilan RI; Shaul YD; Fridlender ZG; Granot Z
Cancer Res; 2018 Sep; 78(17):5050-5059. PubMed ID: 29967257
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme 2 attenuates the metastasis of non-small cell lung cancer through inhibition of epithelial-mesenchymal transition.
Qian YR; Guo Y; Wan HY; Fan L; Feng Y; Ni L; Xiang Y; Li QY
Oncol Rep; 2013 Jun; 29(6):2408-14. PubMed ID: 23545945
[TBL] [Abstract][Full Text] [Related]
15. Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.
Chen J; Lan T; Zhang W; Dong L; Kang N; Zhang S; Fu M; Liu B; Liu K; Zhan Q
Cancer Res; 2015 Oct; 75(19):4198-210. PubMed ID: 26359459
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
[TBL] [Abstract][Full Text] [Related]
17. The biological role of epithelial-mesenchymal transition in lung cancer (Review).
Sung WJ; Kim H; Park KK
Oncol Rep; 2016 Sep; 36(3):1199-206. PubMed ID: 27460444
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-146a inhibits epithelial mesenchymal transition in non-small cell lung cancer by targeting insulin receptor substrate 2.
Park DH; Jeon HS; Lee SY; Choi YY; Lee HW; Yoon S; Lee JC; Yoon YS; Kim DS; Na MJ; Kwon SJ; Kim DS; Kang J; Park JY; Son JW
Int J Oncol; 2015 Oct; 47(4):1545-53. PubMed ID: 26238771
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effects of particulate matter and substrate stiffness on epithelial-to-mesenchymal transition.
Barker TH; Dysart MM; Brown AC; Douglas AM; Fiore VF; Russell AG;
Res Rep Health Eff Inst; 2014 Nov; (182):3-41. PubMed ID: 25669020
[TBL] [Abstract][Full Text] [Related]
20. Nicotine upregulates FGFR3 and RB1 expression and promotes non-small cell lung cancer cell proliferation and epithelial-to-mesenchymal transition via downregulation of miR-99b and miR-192.
Du X; Qi F; Lu S; Li Y; Han W
Biomed Pharmacother; 2018 May; 101():656-662. PubMed ID: 29518612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
